Taken together the expression profile mentioned above, and an increase in expression of CD10 (Fig. 2A), Thy-1 (Fig. 2B), ZEB1, Twist1 and Vimentin (Fig. 3), underscores that MPCs share a molecular signature with claudin-low subtype of breast cancer. This evidence concerns the gene MME and breast cancer.